TrialClinical pharmacokinetics2026

Exposure-Response Analyses to Inform the Optimal Epcoritamab Monotherapy Dosing Regimen in Relapsed or Refractory Follicular Lymphoma.

Mahipal Sinnollareddy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.